SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
8523053
Source:
http://linkedlifedata.com/resource/pubmed/id/8523053
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006142
,
umls-concept:C0021467
,
umls-concept:C0021469
,
umls-concept:C0039286
,
umls-concept:C0043210
,
umls-concept:C0064673
,
umls-concept:C0076836
,
umls-concept:C0439097
,
umls-concept:C0439836
,
umls-concept:C0441994
,
umls-concept:C0587184
,
umls-concept:C1547348
,
umls-concept:C1705241
pubmed:issue
12
pubmed:dateCreated
1996-1-19
pubmed:abstractText
Long-term effects of tamoxifen and toremifene, a new antiestrogen that closely resembles tamoxifen, were investigated on serum lipids and cholesterol metabolism.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8523053-8708737
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol
,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen
,
http://linkedlifedata.com/resource/pubmed/chemical/Toremifene
,
http://linkedlifedata.com/resource/pubmed/chemical/lathosterol
,
http://linkedlifedata.com/resource/pubmed/chemical/zymostenol
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0732-183X
pubmed:author
pubmed-author:GyllingHH
,
pubmed-author:KangasLL
,
pubmed-author:MäenpääHH
,
pubmed-author:MäntyläEE
,
pubmed-author:MiettinenT ATA
,
pubmed-author:PyrhönenSS
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2900-5
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8523053-Antineoplastic Agents, Hormonal
,
pubmed-meshheading:8523053-Breast Neoplasms
,
pubmed-meshheading:8523053-Cholesterol
,
pubmed-meshheading:8523053-Double-Blind Method
,
pubmed-meshheading:8523053-Estrogen Antagonists
,
pubmed-meshheading:8523053-Female
,
pubmed-meshheading:8523053-Humans
,
pubmed-meshheading:8523053-Middle Aged
,
pubmed-meshheading:8523053-Postmenopause
,
pubmed-meshheading:8523053-Tamoxifen
,
pubmed-meshheading:8523053-Toremifene
pubmed:year
1995
pubmed:articleTitle
Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer.
pubmed:affiliation
Department of Medicine, University of Helsinki, Finland.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study